BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24305748)

  • 1. Medical management of early pregnancy failure (EPF): a retrospective analysis of a combined protocol of mifepristone and misoprostol used in clinical practice.
    Colleselli V; Schreiber CA; D'Costa E; Mangesius S; Wildt L; Seeber BE
    Arch Gynecol Obstet; 2014 Jun; 289(6):1341-5. PubMed ID: 24305748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mifepristone and misoprostol for early pregnancy failure: a cohort analysis.
    Kollitz KM; Meyn LA; Lohr PA; Creinin MD
    Am J Obstet Gynecol; 2011 May; 204(5):386.e1-6. PubMed ID: 21306697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
    Sonalkar S; Koelper N; Creinin MD; Atrio JM; Sammel MD; McAllister A; Schreiber CA
    Am J Obstet Gynecol; 2020 Oct; 223(4):551.e1-551.e7. PubMed ID: 32305259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential use of mifepristone and misoprostol in treatment of early pregnancy failure appears more effective than misoprostol alone: a retrospective study.
    van den Berg J; van den Bent JM; Snijders MP; de Heus R; Coppus SF; Vandenbussche FP
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():16-9. PubMed ID: 25461345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked improvement in the success rate of medical management of early pregnancy failure following the implementation of a novel institutional protocol and treatment guidelines: a follow-up study.
    Colleselli V; Nell T; Bartosik T; Brunner C; Ciresa-Koenig A; Wildt L; Marth C; Seeber B
    Arch Gynecol Obstet; 2016 Nov; 294(6):1265-1272. PubMed ID: 27554492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of mifepristone to non-surgical treatment regimens for uterine evacuation in case of early pregnancy failure: a systematic review of the literature.
    van den Berg J; Gordon BBM; Snijders MPML; Vandenbussche FPHA; Coppus SFPJ
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():18-26. PubMed ID: 26461963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of mifepristone and misoprostol for medical treatment of missed miscarriage in clinical practice-A cohort study.
    Ehrnstén L; Altman D; Ljungblad A; Kopp Kallner H
    Acta Obstet Gynecol Scand; 2020 Apr; 99(4):488-493. PubMed ID: 31784973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death.
    Väyrynen W; Heikinheimo O; Nuutila M
    Acta Obstet Gynecol Scand; 2007; 86(6):701-5. PubMed ID: 17520402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of misoprostol for early pregnancy failure.
    Tang OS; Ho PC
    Curr Opin Obstet Gynecol; 2006 Dec; 18(6):581-6. PubMed ID: 17099326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol.
    Haimov-Kochman R; Arbel R; Sciaky-Tamir Y; Brzezinski A; Laufer N; Yagel S
    Acta Obstet Gynecol Scand; 2007; 86(4):462-6. PubMed ID: 17486469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of mifepristone and misoprostol for the termination of pregnancy.
    ;
    Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistency of medical abortion efficacy from 5 through 14 weeks' gestation.
    Garbin O; Vayssiere C; Bettahar-Lebugle K; Nisand I
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):36-40. PubMed ID: 16325992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of miscarriage in a district general hospital is safe and effective up to 12 weeks' gestation.
    Greenland H; Ogunbiyi I; Bugg G; Tasker M
    Curr Med Res Opin; 2003; 19(8):699-701. PubMed ID: 14687439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial.
    Schreiber CA; Creinin MD; Reeves MF; Harwood BJ
    Contraception; 2006 Dec; 74(6):458-62. PubMed ID: 17157102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
    Verhulsdonk MT; Papatsonis DN; Heydanus R
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PURL: Early pregnancy loss: Pretreat with mifepristone?
    Bergeson K; Kline RJ; Prasad S
    J Fam Pract; 2019 Dec; 68(10):668;569;572. PubMed ID: 31860701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
    Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
    Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
    Upadhyay UD; Johns NE; Combellick SL; Kohn JE; Keder LM; Roberts SC
    PLoS Med; 2016 Aug; 13(8):e1002110. PubMed ID: 27575488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.